ADCETRIS (BRENTUXIMAB VEDOTIN) 50MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION, 1 each

Belfast Health and Social Care Trust

This public procurement record has 4 releases in its history.

ContractTermination

08 Oct 2026 at 14:29

Award

06 Jun 2025 at 14:15

Award

21 May 2025 at 10:59

Award

21 May 2025 at 10:55

Summary of the contracting process

Belfast Health & Social Care Trust procured ADCETRIS (brentuximab vedotin), supplied as 50 mg powder for concentrate for solution for infusion. This is a branded prescription medicine used in patient care. The requirement was for the medicine itself, rather than a wider pharmaceutical or clinical service. Delivery was for the Trust in Northern Ireland. The awarded item is described as one vial; the procurement concerns a single medicine and was organised as one lot. The Trust is the public-sector buyer responsible for the requirement.

The procurement was completed by direct award to ALLOGA UK LIMITED, with the stated reason that the branded medicine is patent-protected, essential to patient care and available from only one supplier. The award was made on 21 May 2025, and the contract was signed on 3 June 2025. Its stated value was £700,000. The contract period was 3 June 2025 to 30 June 2027, but the contract was terminated on 14 May 2026. The termination reason is classified only as “other”, with no further explanation. There was one lot and one awarded supplier. The procurement records do not set out separate eligibility requirements or evaluation criteria beyond the sole-supplier rationale for the direct award.

For suppliers assessing similar requirements from Belfast Health & Social Care Trust, this award shows demand for a specific, branded, patent-protected oncology medicine rather than a broad pharmaceutical supply contract. The selected supplier was positioned to supply ADCETRIS (brentuximab vedotin) in the required 50 mg infusion preparation. The buyer justified the direct award on the basis that only one economic operator could supply the medicine, so a credible competitor would need to demonstrate lawful access to the branded product and the ability to supply the precise formulation required for patient care. The award indicates a single-product requirement at substantial scale, but provides no evidence of a broader service, distribution scope or alternative products being included.

How relevant is this notice?

Notice Information

Notice Title

ADCETRIS (BRENTUXIMAB VEDOTIN) 50MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION, 1 each

Notice Description

PROCUREMENT OF ADCETRIS (BRENTUXIMAB VEDOTIN) 50MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION, 1 each

Procurement Information

These are branded patent protected medicines that are essential to patient care and are available from only one economic operator. The absence of competition is not a result of the artificial narrowing of the parameters of the procurement.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-051a10
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/095268-2026
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
UK11 - Contract Termination Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Direct
Procurement Method Details
Direct award
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
£700,000 £500K-£1M
Contracts Value
£700,000 £500K-£1M

Notice Dates

Publication Date
8 Oct 20261 months ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
21 May 20251 years ago
Contract Period
3 Jun 2025 - 30 Jun 2027 2-3 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Active
Contracts Status
Terminated

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
Belfast Health and Social Care Trust
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
BELFAST
Postcode
BT12 6BA
Postcode Area
Northern Ireland
Country
Northern Ireland

Major Region (ITL 1)
TLN Northern Ireland
Basic Region (ITL 2)
TLN0 Northern Ireland
Small Region (ITL 3)
TLN06 Belfast
Delivery Location
Not specified

Local Authority
Belfast
Electoral Ward
Falls
Westminster Constituency
Belfast West

Supplier Information

Number of Suppliers
1
Supplier Name

Alloga UK

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...